Advertisement
Screener

AEON Biopharma, Inc. (AEON) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

AEON Biopharma, Inc. (AEON) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity 355.60%.
  • 2026-03-31: Return Tang Equity 358.82%.
  • 2025-12-31: Return Tang Equity 71.28%.
  • 2025-09-30: Return Tang Equity 0.02%.

Complete source-backed return tang equity history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30355.60%
2026-03-31358.82%
2025-12-3171.28%
2025-09-300.02%
2025-06-3010.32%
2025-03-31-1493.58%
2024-12-31-147.03%
2024-09-30803.33%
2024-06-30955.37%
2024-03-31226.20%
2023-09-30300.06%
2023-06-30680.72%
2023-03-31830.46%
2022-12-3114.04%
2022-09-3048.04%
2022-06-30-85.27%
2022-03-31-32.88%
2021-12-31-48.44%

Annual Return Tang Equity

DateReturn Tang Equity
2025-12-3171.28%
2024-12-31-147.03%
2022-12-3118.28%
2021-12-31-48.44%

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
Tempest Therapeutics, Inc. (TPST)United States$0.013B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Vyome Holdings, Inc (HIND)United States$0.014B-1.38